Primary Outcome Measures:
- Documentation of therapies [ Time Frame: 9 years, 3 years per patient ]
Secondary Outcome Measures:
- Documentation of response rate and adverse reactions; development of a numeric prognostic score [ Time Frame: 9 years ]
The RCC Registry is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with mRCC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.